RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC.
2.61
-0.270 -10.345%
Share volume: 417,539
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.88
-0.27
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 7.922 M | 8.130 M | 8.463 M | 6.538 M | 6.073 M | 4.030 M | |
| Selling general and admin | 2.138 M | 2.545 M | 1.604 M | 2.425 M | 2.348 M | 1.898 M | |
| Research and development | 5.784 M | 5.584 M | 6.858 M | 4.114 M | 3.725 M | 2.131 M | |
| Total expenses | 7.922 M | 8.130 M | 8.463 M | 6.538 M | 6.073 M | 4.030 M | |
| 2.62% | 4.09% | -22.74% | -7.11% | -33.64% | |||
| Operating income | -7.922 M | -8.130 M | -8.463 M | -6.538 M | -6.073 M | -4.030 M | |
| Ebit | -7.596 M | -7.935 M | -8.414 M | -6.502 M | -6.064 M | -4.064 M | |
| Pretax income | -7.426 M | -7.853 M | -8.366 M | -6.428 M | -6.046 M | -4.008 M | |
| 5.74% | 6.54% | -23.17% | -5.94% | -33.71% | |||
| Income tax | 7.396 K | 7.385 K | 0.000 | 5.213 K | 7.954 K | 2.840 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.434 M | -7.860 M | -8.366 M | -6.433 M | -6.054 M | -4.011 M | |
| -5.73% | -6.44% | 23.11% | 5.90% | 33.75% |